Ensayos clínicos

Inclusion Criteria:

• At least 18 years of age (or age of majority).
• Willing to provide consent to participate.
• Meet ONE (1) of the following at the time of enrollment:
  • Diagnosis of chronic pancreatitis (CP);
  • Diagnosis of recurrent acute pancreatitis (RAP).
• Suspected or confirmed diagnosis of EPI made by a healthcare provider.
• On PERT, either prior to the Enrollment Visit or newly prescribed at the time of the Enrollment Visit.

Exclusion Criteria:

• Currently participating in or planning to participate in a double-blind randomized trial and/or open-label Phase 3b/4 on CP or EPI.
• Diagnosed with any of the following conditions at the time of enrollment:
  • Cystic fibrosis;
  • Fibrosing colonopathy;
  • A history of or current diagnosis of pancreatic cancer, main duct papillary mucinous neoplasms (IPMNs), and other pancreatic malignancies;
  • Allergy to pork or other porcine pancreatic enzyme products (PEPs);
  • Any condition that would, in the investigator’s opinion, limit the individual’s ability to complete the study.

Eligibility last updated 9/24/21. Questions regarding updates should be directed to the study team contact.